Steven Fishbane

20.9k total citations · 2 hit papers
179 papers, 10.1k citations indexed

About

Steven Fishbane is a scholar working on Hematology, Nephrology and Genetics. According to data from OpenAlex, Steven Fishbane has authored 179 papers receiving a total of 10.1k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Hematology, 77 papers in Nephrology and 41 papers in Genetics. Recurrent topics in Steven Fishbane's work include Erythropoietin and Anemia Treatment (69 papers), Iron Metabolism and Disorders (53 papers) and Dialysis and Renal Disease Management (51 papers). Steven Fishbane is often cited by papers focused on Erythropoietin and Anemia Treatment (69 papers), Iron Metabolism and Disorders (53 papers) and Dialysis and Renal Disease Management (51 papers). Steven Fishbane collaborates with scholars based in United States, United Kingdom and Sweden. Steven Fishbane's co-authors include Francesco Locatelli, Geoffrey A. Block, Iain C. Macdougall, John K. Maesaka, Bruce Spinowitz, Kenar D. Jhaveri, Pablo E. Pérgola, Paula Dutka, Giovanni FM Strippoli and Anatole Besarab and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Steven Fishbane

171 papers receiving 9.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients

2017 3.1k citations Francesco Locatelli, Steven Fishbane et al. American Journal of Nephrology profile →
Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies

2013 585 citations Suetonia C. Palmer, Jonathan C. Craig et al. Kidney International profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Steven Fishbane United States	45	3.5k	3.5k	1.9k	1.6k	1.6k	179	10.1k
Iain C. Macdougall United Kingdom	49	6.6k 1.9×	2.7k 0.8×	3.1k 1.6×	1.7k 1.0×	1.0k 0.6×	187	12.0k
Tadao Akizawa Japan	53	2.9k 0.8×	8.8k 2.5×	1.0k 0.5×	1.1k 0.7×	1.8k 1.1×	442	13.6k
Jack F.M. Wetzels Netherlands	66	1.5k 0.4×	8.1k 2.3×	1.3k 0.7×	3.4k 2.0×	2.8k 1.8×	394	14.3k
Jérôme Rossert France	44	1.8k 0.5×	4.6k 1.3×	621 0.3×	1.5k 0.9×	1.5k 0.9×	107	11.4k
Geoffrey A. Block United States	50	1.5k 0.4×	9.4k 2.7×	731 0.4×	2.0k 1.2×	2.8k 1.7×	160	14.8k
Jolanta Małyszko Poland	42	1.3k 0.4×	2.5k 0.7×	715 0.4×	1.2k 0.7×	1.1k 0.7×	559	8.0k
Yasuhiko Tomino Japan	57	2.1k 0.6×	11.0k 3.1×	855 0.4×	3.7k 2.2×	2.5k 1.6×	626	19.7k
Sunil Bhandari United Kingdom	39	1.7k 0.5×	3.7k 1.0×	1.1k 0.6×	1.1k 0.7×	1.9k 1.2×	203	11.3k
Francesco Locatelli Italy	75	8.0k 2.3×	13.3k 3.8×	2.9k 1.5×	2.6k 1.6×	3.2k 2.0×	539	25.2k
Xiangmei Chen China	52	485 0.1×	3.7k 1.1×	803 0.4×	3.3k 2.0×	1.1k 0.7×	578	10.8k

Countries citing papers authored by Steven Fishbane

Since Specialization

Citations

This map shows the geographic impact of Steven Fishbane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Fishbane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Fishbane more than expected).

Fields of papers citing papers by Steven Fishbane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Fishbane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Fishbane. The network helps show where Steven Fishbane may publish in the future.

Co-authorship network of co-authors of Steven Fishbane

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Fishbane. A scholar is included among the top collaborators of Steven Fishbane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Fishbane. Steven Fishbane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pecoits‐Filho, Roberto, Eiichiro Kanda, Naoki Kashihara, et al.. (2025). Characteristics and cardio-renal outcomes in patients with CKD receiving guideline-directed medical therapy: insights from DISCOVER CKD. Nephrology Dialysis Transplantation. 41(3). 500–510.

Sprague, Stuart M., Daniel E. Weiner, Pablo E. Pérgola, et al.. (2024). Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study. Kidney360. 5(5). 732–742. 7 indexed citations

Pollock, Carol A., Juan Jesús Carrero, Eiichiro Kanda, et al.. (2024). The Lived Experience of Patients With Chronic Kidney Disease: Insights From DISCOVER CKD. American Journal of Nephrology. 55(6). 618–628.

Jhaveri, Kenar D., et al.. (2022). Haplo-Storm Induced AKI. Journal of the American Society of Nephrology. 33(11S). 376–376.

Pérgola, Pablo E., Chaim Charytan, Dustin J. Little, et al.. (2022). Changes in Iron Availability with Roxadustat in Nondialysis- and Dialysis-Dependent Patients with Anemia of CKD. Kidney360. 3(9). 1511–1528. 13 indexed citations

Fishbane, Steven, Martin L. Ford, Masafumi Fukagawa, et al.. (2022). Potassium responses to sodium zirconium cyclosilicate in hyperkalemic hemodialysis patients: post-hoc analysis of DIALIZE. BMC Nephrology. 23(1). 59–59. 7 indexed citations

Winkelmayer, Wolfgang C., Steven Fishbane, James A. Tumlin, et al.. (2021). Iron-Related Outcomes in Patients with Dialysis-Dependent CKD Randomized to Vadadustat vs. Darbepoetin Alfa. Journal of the American Society of Nephrology. 32(10S). 182–182. 1 indexed citations

Fishbane, Steven, David M. Charytan, Glenn M. Chertow, et al.. (2021). Consensus-Based Recommendations for the Management of Hyperkalemia in the Hemodialysis Setting. Journal of Renal Nutrition. 32(4). e1–e14. 10 indexed citations

Rastogi, Anjay, Roberto Pecoits‐Filho, Steven Fishbane, et al.. (2020). Roxadustat Treatment Corrects Anemia to Hemoglobin (Hb) Values ≥10 g/dL in the Majority of Patients with Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD). Journal of the American Society of Nephrology. 31(10S). 133–133. 1 indexed citations

10.

Provenzano, Robert, Steven Fishbane, Daniel W. Coyne, et al.. (2020). Roxadustat Treatment of Anemia in Non-Dialysis-Dependent CKD Is Not Influenced by Iron Status. Journal of the American Society of Nephrology. 31(10S). 1–1. 1 indexed citations

11.

Fishbane, Steven & Bruce Spinowitz. (2018). Update on Anemia in ESRD and Earlier Stages of CKD: Core Curriculum 2018. American Journal of Kidney Diseases. 71(3). 423–435. 181 indexed citations

12.

McCullough, P. R., Pablo E. Pérgola, Steven Fishbane, et al.. (2017). Abstract 16610: Efficacy and Safety of Sodium Zirconium Cyclosilicate to Treat Hyperkalemia Among Patients Taking Renin-Angiotensin-Aldosterone System Inhibitors in a 12-Month, Open-Label, Phase 3 Study: A Post Hoc Subgroup Analysis. Circulation. 2 indexed citations

13.

Locatelli, Francesco, Steven Fishbane, Geoffrey A. Block, & Iain C. Macdougall. (2017). Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients. American Journal of Nephrology. 45(3). 187–199. 3099 indexed citations breakdown →

14.

Shah, Hitesh H., Azzour D. Hazzan, & Steven Fishbane. (2016). Ferric Pyrophosphate Citrate: A Novel Iron Replacement Agent in Patients Undergoing Hemodialysis. Seminars in Nephrology. 36(2). 124–129. 12 indexed citations

15.

Wish, Jay B., Chaim Charytan, Glenn M. Chertow, et al.. (2016). Introduction of Biosimilar Therapeutics Into Nephrology Practice in the United States: Report of a Scientific Workshop Sponsored by the National Kidney Foundation. American Journal of Kidney Diseases. 68(6). 843–852. 7 indexed citations

16.

Mathew, Anna, Giovanni FM Strippoli, Marinella Ruospo, & Steven Fishbane. (2015). Reducing hospital readmissions in patients with end-stage kidney disease. Kidney International. 88(6). 1250–1260. 54 indexed citations

17.

Tong, Allison, Suetonia C. Palmer, Braden Manns, et al.. (2012). Clinician beliefs and attitudes about home haemodialysis: a multinational interview study. BMJ Open. 2(6). e002146–e002146. 19 indexed citations

18.

Fishbane, Steven & Anatole Besarab. (2007). Mechanism of Increased Mortality Risk with Erythropoietin Treatment to Higher Hemoglobin Targets. Clinical Journal of the American Society of Nephrology. 2(6). 1274–1282. 106 indexed citations

19.

Fishbane, Steven. (2006). Editorials: Recombinant Human Erythropoietin: Has Treatment Reached its Full Potential?. Seminars in Dialysis. 19(1). 1–4. 24 indexed citations

20.

Fishbane, Steven. (2006). Refractory anemia in a patient with allergy to intravenous iron drugs. Kidney International. 69(10). 1910–1913. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact